International Journal of General Medicine (Feb 2022)

Clinical-Epidemiological Characteristics and Mortality in Patients with Sickle Cell Anemia: A Retrospective Cohort Study of 1980 at 2018

  • Pompeo CM,
  • Ferreira Júnior MA,
  • Cardoso AIDQ,
  • Souza MDC,
  • Frota OP,
  • Mota FM,
  • Ivo ML

Journal volume & issue
Vol. Volume 15
pp. 1057 – 1074

Abstract

Read online

Carolina Mariano Pompeo,1 Marcos Antonio Ferreira Júnior,1 Andreia Insabralde de Queiroz Cardoso,1 Mercy da Costa Souza,2 Oleci Pereira Frota,1 Felipe Machado Mota,1 Maria Lúcia Ivo2 1Integrated Institute of Health, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil; 2Graduate Program in Health and Development in the Midwest Region, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, BrazilCorrespondence: Carolina Mariano PompeoIntegrated Institute of Health, Federal University of Mato Grosso do Sul, Campo Grande, Mato Grosso do Sul, Brazil, Tel +55 67 99984-7048, Email [email protected]: To analyze the clinical-epidemiological characteristics and mortality in patients with sickle-cell anemia (SCA).Patients and Methods: A cohort study with retrospective data, conducted in two reference hospitals for SCA treatment from January 1980 to December 2018, recorded in two reference services. With a 5% significance level, the Chi-Square and Student’s t-tests were employed in the inferential statistical analysis.Results: A total of 128 patients with SCA were studied. Diagnosis up to the fifth day of life was made in 10 patients. There were 19 deaths, of which 12 (63.2%) were female, and the average age at death was 27.05 (± 14.78) years. The leading causes of death were septic shock and cardiogenic shock. The use of invasive medical devices was considered a risk factor for death (RR=2.63; 95% CI=1.16– 5.96; p=0.018), and monitoring time up to 20 years presented a 31% reduction in the risk of dying (RR=0.31; 95% CI=0.12– 0.82; p=0.011) when compared to the monitoring of more than 20 years.Conclusion: These findings are to be considered in the treatment of patients with SCA, mainly regarding early diagnosis and access to the treatment immediately afterward, since they are fundamental in improving survival and reducing severe complications.Keywords: hematologic diseases, early diagnosis, neonatal screening, survival, epidemiology

Keywords